Literature DB >> 1647028

Phosphorylation of protein 4.1 on tyrosine-418 modulates its function in vitro.

G Subrahmanyam1, P J Bertics, R A Anderson.   

Abstract

Protein 4.1 was initially characterized as a protein that regulates cytoskeletal assembly in erythrocytes. However, recent studies have shown that protein 4.1 is ubiquitous in mammalian cells. Here, we show that protein 4.1 is phosphorylated on tyrosine by the epidermal growth factor receptor (EGFR) tyrosine kinase. The phosphorylation site has been localized to the 8-kDa domain, which has one tyrosine, tyrosine-418. The 8-kDa region is required for the assembly of the spectrin/actin complex, and phosphorylation by EGFR reduced the ability of protein 4.1 to promote the assembly of the spectrin/actin/protein 4.1 ternary complex. Immunoblotting with anti-phosphotyrosine antibodies showed that purified protein 4.1 contained phosphorylated tyrosine, and this increased upon phosphorylation by EGFR. This suggests that tyrosine phosphorylation of protein 4.1 occurs in vivo and may be functionally significant. The tyrosine phosphorylation site is in the center of a sequence motif that is expressed by a differentiation-specific splicing mechanism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1647028      PMCID: PMC51844          DOI: 10.1073/pnas.88.12.5222

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Differential phosphorylation of multiple sites in protein 4.1 and protein 4.9 by phorbol ester-activated and cyclic AMP-dependent protein kinases.

Authors:  W C Horne; T L Leto; V T Marchesi
Journal:  J Biol Chem       Date:  1985-08-05       Impact factor: 5.157

3.  Role of phosphatidylinositol kinase in PDGF receptor signal transduction.

Authors:  S R Coughlin; J A Escobedo; L T Williams
Journal:  Science       Date:  1989-03-03       Impact factor: 47.728

4.  Platelet-derived growth factor induces multisite phosphorylation of pp60c-src and increases its protein-tyrosine kinase activity.

Authors:  K L Gould; T Hunter
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

5.  Tissue-specific analogues of erythrocyte protein 4.1 retain functional domains.

Authors:  R A Anderson; I Correas; C Mazzucco; J D Castle; V T Marchesi
Journal:  J Cell Biochem       Date:  1988-07       Impact factor: 4.429

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Structure of the spectrin-actin binding site of erythrocyte protein 4.1.

Authors:  I Correas; D W Speicher; V T Marchesi
Journal:  J Biol Chem       Date:  1986-10-05       Impact factor: 5.157

8.  Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro.

Authors:  J Meisenhelder; P G Suh; S G Rhee; T Hunter
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

9.  Regulation of the association of membrane skeletal protein 4.1 with glycophorin by a polyphosphoinositide.

Authors:  R A Anderson; V T Marchesi
Journal:  Nature       Date:  1985 Nov 21-27       Impact factor: 49.962

10.  Rapid phosphorylation and reorganization of ezrin and spectrin accompany morphological changes induced in A-431 cells by epidermal growth factor.

Authors:  A Bretscher
Journal:  J Cell Biol       Date:  1989-03       Impact factor: 10.539

View more
  15 in total

1.  A nonerythroid isoform of protein 4.1R interacts with components of the contractile apparatus in skeletal myofibers.

Authors:  A Kontrogianni-Konstantopoulos; S C Huang; E J Benz
Journal:  Mol Biol Cell       Date:  2000-11       Impact factor: 4.138

2.  Homozygous 4.1(-) hereditary elliptocytosis associated with a point mutation in the downstream initiation codon of protein 4.1 gene.

Authors:  N Dalla Venezia; F Gilsanz; N Alloisio; M T Ducluzeau; E J Benz; J Delaunay
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

3.  Inhibition of protein 4.1 R and NuMA interaction by mutagenization of their binding-sites abrogates nuclear localization of 4.1 R.

Authors:  Subhendra N Mattagajasingh; Shu-Ching Huang; Edward J Benz
Journal:  Clin Transl Sci       Date:  2009-04       Impact factor: 4.689

4.  Regulated Fox-2 isoform expression mediates protein 4.1R splicing during erythroid differentiation.

Authors:  Guang Yang; Shu-Ching Huang; Jane Y Wu; Edward J Benz
Journal:  Blood       Date:  2007-08-22       Impact factor: 22.113

5.  Mitotic regulation of protein 4.1R involves phosphorylation by cdc2 kinase.

Authors:  Shu-Ching Huang; Eva S Liu; Siu-Hong Chan; Indira D Munagala; Heidi T Cho; Ramasamy Jagadeeswaran; Edward J Benz
Journal:  Mol Biol Cell       Date:  2004-11-03       Impact factor: 4.138

6.  Tyrosine phosphorylation of a membrane protein from Pseudomonas solanacearum.

Authors:  M Atkinson; C Allen; L Sequeira
Journal:  J Bacteriol       Date:  1992-07       Impact factor: 3.490

7.  Phosphorylation-dependent perturbations of the 4.1R-associated multiprotein complex of the erythrocyte membrane.

Authors:  Emilie Gauthier; Xinhua Guo; Narla Mohandas; Xiuli An
Journal:  Biochemistry       Date:  2011-05-06       Impact factor: 3.162

8.  Alteration of the kinetic properties of the epidermal growth factor receptor tyrosine kinase by basic proteins.

Authors:  L Hubler; P S Leventhal; P J Bertics
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

9.  Characterization of the hypertonically induced tyrosine phosphorylation of erythrocyte band 3.

Authors:  G Minetti; C Seppi; A Ciana; C Balduini; P S Low; A Brovelli
Journal:  Biochem J       Date:  1998-10-15       Impact factor: 3.857

10.  Cytoskeletal protein 4.1R negatively regulates T-cell activation by inhibiting the phosphorylation of LAT.

Authors:  Qiaozhen Kang; Yu Yu; Xinhong Pei; Richard Hughes; Susanne Heck; Xihui Zhang; Xinhua Guo; Gregory Halverson; Narla Mohandas; Xiuli An
Journal:  Blood       Date:  2009-02-03       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.